This video is sponsored by the Duke Clinical Medical Series.
The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.
The guest faculty, A. Michael Lincoff, MD, has indicated that he receives research/grant
support from The Medicines Company, Centocor, and Sanofi Aventis, and that he received an
honorarium from the Medicines Company.
|
|